Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Farewell to Terawan's Vaccine

Translator

TEMPO

Editor

Laila Afifa

30 April 2021 07:08 WIB

Former Minister of Health Terawan Agus Putranto during a working meeting with Commission IX of the DPR RI at the Senayan Parliament Complex, Jakarta, Wednesday, March 10, 2021. However, on the same occasion, the Food and Drug Supervisory Agency (BPOM) has not given the green light regarding the Implementation Approval. Clinical trials or PPUK clinical trials II and III of Nusantara vaccines initiated by Terawan. TEMPO / M Taufan Rengganis

TEMPO.CO, JakartaThere is no longer any need for the government to be responsible for research into the Nusantara vaccine being promoted by former Minister of Health Terawan Agus Putranto. None of the claims about it have been tested clinically.

Rather than continuing to make faceless claims about the effectiveness of the Nusantara vaccine, former minister of health Terawan Agus Putranto would do better to concentrate on preparing himself for his new job as Indonesian ambassador to Spain. If his actions in inviting politicians and former officials to become guinea pigs for the vaccine are continued, Terawan runs the risk of committing further violations of research ethics and triggering a protracted polemic.

Since it was introduced to the public as the "Nusantara Vaccine" at the beginning of this year, the research carried out by Terawan and colleague Taruna Ikrar has been controversial. Even the name is a problem. It is now known that the research based on the dendritic cell method was not carried out by Indonesians. Taruna, who is also head of the Indonesian medical Council learned about this experiment from his partner in the United States. The method was discovered by Aivita Biomedical Inc, which is based in Irvine California thousands of kilometers from Indonesia.

The hasty and secretive preparations for the Nusantara vaccine research have also led to suspicions. In his position as minister, Terawan the Ministry of Health Research and Development Agency to sponsor the research. There are allegations that he pushed the agency to allocate Rp29 billion in funding and to appoint Dr. Kariadi Public Hospital in Semarang, Central Java, as the research site. These alleged abuses of power by Terawan should be investigated.

Moreover, subsequent audit by the Indonesian Food and Drug Monitoring Agency (BPOM) discovered a number of problems in the phase one clinical trials. As well as the research participant volunteers all having been previously infected with the Coronavirus, meaning they were not suitable to be test subjects for the vaccine, the role of Aivita in the experimental progress was not mentioned in violation of the regulations. The number of research preconditions violated lead to the BPOM deferring the permit for phase 2 clinical trials on the Nusantara vaccine.

And this is where all the fuss started. A number of members of the House of Representatives (DPR) seemingly felt that their authority as lawmakers exceeded the bounds of science. These politicians may have believed that their wishes were equivalent to legal requirements and that any commands they issued could not be questioned. After failing to force the BPOM to grant a permit for phase 2 clinical trials and number of DPR members demonstrated their feelings by volunteering to take the Nusantara vaccine. One by one they went to the Gatot Soebroto Central Army Hospital (RSPAD) to receive treatment from Terawan.

A number of well-known figures followed their example, from former Golkar party general chairman Aburizal Bakrie and former state-owned enterprises minister Dahlan Iskan, to former cabinet secretary Sudi Silalahi and former Indonesian Military commander General (ret) Gatot Nurmantyo. All of them said that they had been invited by Terawan to try for themselves this therapy that had not yet been scientifically tested. Their conduct not only endangered their own health, but also demonstrated an anti-science stance. They explicitly rejected the medical authority and generally accepted scientific methodology. It was this that prompted hundreds of public figures to sign a petition expressing support for BPOM and the body's insistence on preserving scientific principles in the issuing of research permits for medicine and vaccinations.

The swift move by Coordinating Minister for Human Development and Culture Muhadjir Effendy to hold meeting with BPOM Head Penny Lukito, Indonesian Military Chief of Staff General Andika Perkasa and Health Minister Budi Gunadi Sadikin at the end of last week was the right thing to do the memorandum of understanding that they signed automatically ended the Nusantara vaccine polemic by emphasizing that Terawan's research would not lead to mass production.

Despite this, there are number of questions remaining unanswered from this agreement. Example who funded the further Nusantara vaccine research at the RSPAD and what guarantees of safety are there for the volunteers if there are negative side effects from this dendritic therapy? Rather than continuing to be vague, the government should clearly state that any continuation of the Nusantara vaccine will be entirely in the private sector without any state intervention.

This is the policy of the government of the United States towards Aivita Biomediacal Inc, which is now trying to obtain a permit for a clinical trials there. Let the Nusantara vaccine research be tested using the scientific method without politicization or nationalistic propaganda. Only if this dendritic cell therapy scientifically proved to be effective in fighting the Covid-19 pandemic will we enthusiastically welcome it.

Read the Complete Story in Tempo English Magazine



Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

20 hari lalu

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

The recovery in the aviation sector post-COVID-19 pandemic has reached 83 percent.


How India's COVID Lockdowns Impacted Menstrual Health

33 hari lalu

How India's COVID Lockdowns Impacted Menstrual Health

Limited access to period products during India's COVID lockdown highlighted how far public health initiatives have to go when it comes to menstruation


How Do You Eliminate or Eradicate an Infectious Disease?

33 hari lalu

How Do You Eliminate or Eradicate an Infectious Disease?

The COVID-19 pandemic gave the world a crash course in epidemiology and showed in real time how an infectious disease can spread or be contained.


Why Have Efforts to Eradicate TB Been So Slow?

37 hari lalu

Why Have Efforts to Eradicate TB Been So Slow?

Tuberculosis (TB) is one of the world's most deadly infectious diseases - but the COVID-19 pandemic dramatically slowed efforts to eliminate it.


Depok Records 200% Hike in COvid-19 Cases Last December

3 Januari 2024

Depok Records 200% Hike in COvid-19 Cases Last December

Depok Mayor Mohammad Idris revealed that the number of Covid-19 cases in the city surged from 100 to 300 as of December 2023


Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

2 Januari 2024

Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.


Self-paid COVID-19 Vaccination Program to Start in 2024

28 Desember 2023

Self-paid COVID-19 Vaccination Program to Start in 2024

The Jakarta Health Agency is set to begin implementing the self-paid COVID-19 vaccination starting January 1, 2024.


Jakarta to Celebrate New Year's Eve with 'Malam Muda Mudi'

27 Desember 2023

Jakarta to Celebrate New Year's Eve with 'Malam Muda Mudi'

The Jakarta provincial government is set to hold Malam Muda Mudi, or the Night of the Youths, to enliven the 2024 New Year's Eve celebrations.


Indonesia Sees Rising Cases of Covid-19 Ahead of Year-end

26 Desember 2023

Indonesia Sees Rising Cases of Covid-19 Ahead of Year-end

Nearing the end of 2023, the Health Ministry recorded that the spread of Covid-19 variant JN.1 in Indonesia continues to increase, reaching 41 cases.


Indonesia's Health Ministry Reports Deaths of Two Omicron JN.1 Patients in Batam

26 Desember 2023

Indonesia's Health Ministry Reports Deaths of Two Omicron JN.1 Patients in Batam

The Indonesian Ministry of Health reports the death of two patients infected with the Omicron JN.1 and XBB.2.3.10.1 (GE.1) sub-variants of Covid-19.